Introduction:

The pharmacological burden in hemodialysis patients exceeds that of other chronic patients, non- adherence to treatment has implications for quality of life, survival and the economic cost of their treatment. The objective was to evaluate the health-related quality of life score according to the type of adherence to treatment in patients on hemodialysis therapy.

Methods:

The study is observational, prospective, cross-sectional and descriptive, the study universe is made up of patients who received hemodialysis at COSSMIL during 2020, the sample was 27 patients, adherence to treatment was measured by through the Morisky-Green Test and health-related quality of life using the 36-item Kidney Disease Quality of Life.

Results:

A total of 7 patients adherent to the treatment (25.9%) were found. On the scale from 1 to 100, 100% of the scores for the mental component and 96.3% for the physical component were less than the reference score of 50. The subscale of kidney disease burden obtained scores of 0.

Conclusion:

The quality of life of these patients is significantly affected, with no differences related to the type of treatment adherence. The subscale of renal disease burden expresses the greatest impact on the quality of life. There is a need to strengthen a comprehensive, multidisciplinary, and biopsychosocial clinical approach that includes coping strategies and psychosocial support to address the socioemotional challenges associated with chronic kidney disease.